Charles E. Hart

Dr. Hart brings over 30 years of cross-functional experience in the biotechnology field where he has focused on the development of human therapeutics and medical devices. Throughout his career, much of this effort has been on the development of products to stimulate tissue repair/regeneration, including both acute and chronic indications. His background has spanned a broad array of areas across the healthcare/biotechnology space including preclinical research, clinical development, process development, manufacturing, regulatory affairs, business development, intellectual property, corporate communications and investor relations. Most recently, Dr. Hart was Vice President of Research for the Regenerative Medicine Division at Shire Pharmaceuticals. From 2009 to 2011 he was Vice President and Chief Scientific Officer at Advanced BioHealing, Inc., a company focused on the development of cell-based therapies for the treatment of chronic wounds, which was acquired by Shire in 2011. From 2004 to 2008 he served as Vice President and Chief Scientific Officer at BioMimetic Therapeutics, a company focused on the development of protein/device combination products for the treatment of various musculoskeletal injuries, including both bone and soft tissues. Prior to joining BioMimetic he spent 21 years at ZymoGenetics, Inc., a biotechnology company focused on therapeutic proteins, where he held a variety of leadership positions. During his career Dr. Hart has authored over 60 scientific publications and holds over 35 US patents. Dr. Hart received his Ph.D. from the University of Washington, his M.S. from Oregon State University and his B.S. from the University of California at Davis.